Skip to main content
. 2016 Aug 3;7:1182. doi: 10.3389/fmicb.2016.01182

Table 2.

Antifungal activity in membrane assays.

PDA PDA plus acetamide
Cellophane Dialysis Cellophane Dialysis
R. solani T34 48.25 ± 8.17a 36.10 ± 7.05a 56.87 ± 3.75a 21.41 ± 3.43a
amdS6 55.50 ± 4.10a 42.81 ± 5.06a 38.44 ± 8.17b 15.02 ± 7.34a
amdS122 55.26 ± 3.64a 48.56 ± 6.23a 28.75 ± 7.21b 4.79 ± 1.98b
B. cinerea T34 74.31 ± 7.17a 66.26 ± 2.67a 76.09 ± 3.95a 69.85 ± 0.73a
amdS6 65.47 ± 3.22a 67.72 ± 2.97a 44.29 ± 8.28b 35.50 ± 7.99b
amdS122 69.89 ± 2.20a 67.23 ± 0.80a 48.37 ± 5.52b 31.72 ± 7.60b
F. oxysporum T34 34.62 ± 6.50b 23.74 ± 4.75b 46.03 ± 3.24a 32.79 ± 5.68a
amdS6 50.64 ± 1.28a 40.91 ± 4.18a 35.98 ± 3.07b 15.57 ± 6.76b
amdS122 58.55 ± 4.98a 35.86 ± 4.30a 31.59 ± 3.16b 14.75 ± 6.56b

Percentages of growth inhibition of R. solani, B. cinerea, and F. oxysporum by T. harzianum wild type (T34), and amdS transformants (amdS6 or amdS122) grown on cellophane or dialysis membranes on PDA or PDA plus 10 mM acetamide plates.

Values are the means of three biological replicates. For each pathogen, type of membrane, and medium, values followed by different letters in each column are significantly different (P < 0.05).